| Active ingredient (INN) | Ketorolac Tromethamine |
|---|---|
| Therapeutic category | Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | TEVA PHARMACEUTICALS USA, INC., BAXTER HEALTHCARE CORPORATION, Hospira, Inc., MICRO LABS LIMITED |
|---|
| Registrations on file | 5 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Ketorolac Tromethamine | 10mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| KETOROLAC TROMETHAMINE | 15mg/mL | injection | 🇺🇸 US | BAXTER HEALTHCARE CORPORATION | Active |
| KETOROLAC TROMETHAMINE | 30mg/mL | injection | 🇺🇸 US | BAXTER HEALTHCARE CORPORATION | Active |
| Ketorolac Tromethamine | 60mg/2mL | injection | 🇺🇸 US | Hospira, Inc. | Active |
| Ketorolac Tromethamine | 5mg/mL | solution | 🇺🇸 US | MICRO LABS LIMITED | Active |